GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Labiana Health SA (XMAD:LAB) » Definitions » Change In Payables And Accrued Expense

Labiana Health (XMAD:LAB) Change In Payables And Accrued Expense : €0.00 Mil (TTM As of Dec. 2022)


View and export this data going back to 2022. Start your Free Trial

What is Labiana Health Change In Payables And Accrued Expense?

Labiana Health's Change In Payables And Accrued Expense for the quarter that ended in Dec. 2022 was €0.00 Mil. It means Labiana Health's Accounts Payable & Accrued Expense stayed the same from Jun. 2022 to Dec. 2022 .

Labiana Health's Change In Payables And Accrued Expense for the fiscal year that ended in Dec. 2022 was €0.00 Mil. It means Labiana Health's Accounts Payable & Accrued Expense stayed the same from Dec. 2021 to Dec. 2022 .


Labiana Health Change In Payables And Accrued Expense Historical Data

The historical data trend for Labiana Health's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Labiana Health Change In Payables And Accrued Expense Chart

Labiana Health Annual Data
Trend Dec20 Dec21 Dec22
Change In Payables And Accrued Expense
- - -

Labiana Health Semi-Annual Data
Dec20 Dec21 Jun22 Dec22
Change In Payables And Accrued Expense - - - -

Labiana Health Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Dec. 2022 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Labiana Health Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of Labiana Health's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Labiana Health (XMAD:LAB) Business Description

Industry
Traded in Other Exchanges
N/A
Address
Avenida Europa, 34 1st D, Pozuelo de Alarcon, Madrid, ESP, 28023
Labiana Health SA is a manufacturer of pharmacological products for veterinary use. The company's activities include GMP manufacturer for EU animal and human health industries, manufacturer specialized in sterile and lyophilized dosage forms, source of development, acquisition, and licensing of molecules such as Fosfomycin Trometamol.